My Account Log in

3 options

Dissecting oncogenic signaling by BCR/ABL and notch / Yiping He.

Holman Biotech Commons Thesis H432 2002
Loading location information...

Available This item is available for access.

Log in to request item
LIBRA Diss. POPM2002.296
Loading location information...

Available from offsite location This item is stored in our repository but can be checked out.

Log in to request item
LIBRA Microfilm P38:2002
Loading location information...

Mixed Availability Some items are available, others may be requested.

Log in to request item
Format:
Book
Manuscript
Microformat
Thesis/Dissertation
Author/Creator:
He, Yiping.
Contributor:
Pear, Warren S., advisor.
University of Pennsylvania.
Language:
English
Subjects (All):
Penn dissertations--Cell and molecular biology.
Cell and molecular biology--Penn dissertations.
Cell and Molecular Biology.
Academic Dissertations as Topic.
Medical Subjects:
Cell and Molecular Biology.
Academic Dissertations as Topic.
Local Subjects:
Penn dissertations--Cell and molecular biology.
Cell and molecular biology--Penn dissertations.
Physical Description:
xvii, 174 pages : illustrations ; 29 cm
Production:
2002.
Summary:
In leukemia, chromosomal translocations result in oncogene activation. Two outcomes of chromosomal translocation are formation of fusion proteins and inappropriate expression of oncogenes. Here, we study the roles of two chromosomal translocation derived oncoproteins, Bcr/Abl and truncated Notch1, in hematopoietic transformation and development.
Bcr/Abl, the product of the t(9; 22) translocation, encodes a fusion oncoprotein with constitutive tyrosine kinase activity. Bcr/Abl is associated with chronic myelogenous leukemia (CML) and is composed of Bcr sequences at the amino-terminus and c-Abl sequences at the carboxyl-terminus. Utilizing a murine CML model to study the role of Bcr in CML pathogenesis, we identified two domains that are required for CML induction: (1) an amino-terminal oligomerization domain and (2) a tyrosine at position 177. These studies provide the basis for investigating the mechanism by which Bcr contributes to CML.
Notch1 is a transmembrane protein that functions in cell fate specification. Upon chromosomal translocation, much of the sequences encoding the extracellular domain of Notch1 are removed and the truncated transcript is placed under the transcriptional control of the TCRbeta locus. This results in the inappropriately expressed and activated Notch1, which is a transcriptional activator and is associated with T cell lymphocytic leukemia (TALL). Constitutively active Notch signaling promotes ectopic T cell development at the expense of B cell development, and also causes T-ALL in mice. Here, the function of Notch signaling in B cells was assessed. We found that activated Notch1 is a potent inducer of murine B cell death and both cell lines and primary cells were susceptible to Notch killing. The cell death induction was accompanied by upregulation of Hes1 transcript. Overexpression of Hes1 also induced B cell death, suggesting that the activity of Notch in B cells is mediated, at least partially, by Hes1. Additionally, Hes1 overexpression in vivo mimics the activity of Notch in B cells, but fails to induce ectopic T cell development. Thus, signals downstream from Notch have specialized roles in mediating Notch phenotypes. Furthermore, these studies illustrate that the outcome of Notch signaling is cell context dependent.
Notes:
Adviser: Warren S. Pear.
Thesis (Ph.D. in Cell and Molecular Biology) -- University of Pennsylvania, 2002.
Includes bibliographical references.
Local Notes:
University Microfilms order no.: 3073009.
OCLC:
244972854

The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.

Find

Home Release notes

My Account

Shelf Request an item Bookmarks Fines and fees Settings

Guides

Using the Find catalog Using Articles+ Using your account